Company / Return on Assets (ROA)
Haemonetics Return on Assets (ROA) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
7.6%
FY2024
5-year range
2.4% / 7.6%
FY2020-FY2024
Trend
+25.7%
vs FY2023
Sector context
#32 of 158
Health Care
What the data says
Haemonetics's return on assets (roa) of 7.6% is higher than 80% of companies in the Health Care sector (FY2024). Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -2.0% in FY2016 to 7.6% in FY2024.
Based on SEC 10-K filings.
7.6% in FY2024 with a 5-year CAGR of +1.6%. Top quartile in the Health Care sector.
Improved from 6.2% to 7.6% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +5.3pp
- 5-Year Change
- +1.6pp
- 10-Year Change
- -
Sector benchmark
+454.0% above sector average
Key checks
Key Insights
- In FY2024, return on assets (roa) increased 25.7% year-over-year.
- Currently 9.8pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | 7.6% | +25.7% |
| FY2023 | 6.1% | -2.1% |
| FY2022 | 6.2% | +160.9% |
| FY2021 | 2.4% | -62.0% |
| FY2020 | 6.3% | +4.5% |
| FY2019 | 6.0% | +34.8% |
| FY2018 | 4.5% | +20.9% |
| FY2017 | 3.7% | +284.9% |
| FY2016 | -2.0% | +46.8% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026